Pregled bibliografske jedinice broj: 369730
Adenovirus Mediated p53 or p21WAF1/CIP1 Gene Transfer and its Impact on Cancer Therapy
Adenovirus Mediated p53 or p21WAF1/CIP1 Gene Transfer and its Impact on Cancer Therapy // Workshop Adenoviruses Basic Biology to Gene Therapy : programme and abstracts / Majhen, Dragomira ; Ambriović-Ristov, Andreja (ur.).
Zagreb: Hrvatsko mikrobiološko društvo, 2008. str. 8-8 (pozvano predavanje, nije recenziran, sažetak, znanstveni)
CROSBI ID: 369730 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Adenovirus Mediated p53 or p21WAF1/CIP1 Gene Transfer and its Impact on Cancer Therapy
Autori
Kralj, Marijeta
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Workshop Adenoviruses Basic Biology to Gene Therapy : programme and abstracts
/ Majhen, Dragomira ; Ambriović-Ristov, Andreja - Zagreb : Hrvatsko mikrobiološko društvo, 2008, 8-8
ISBN
978-953-96567-6-6
Skup
Workshop Adenoviruses Basic Biology to Gene Therapy
Mjesto i datum
Zadar, Hrvatska, 24.09.2008. - 27.09.2008
Vrsta sudjelovanja
Pozvano predavanje
Vrsta recenzije
Nije recenziran
Ključne riječi
adenoviruses; chemotrepary; gene therapy; p53; p21
Sažetak
One of the new approaches to therapy is to restore apoptotic potential by gene therapy. Among the most important genes that regulate the apoptotic program is the p53 gene – so called "a master regulator". Based on this, the gene replacement therapy with wtp53, mainly using adenoviral vectors, provides an attractive strategy to cancer treatment, and the first gene-based therapeutic – Gendicine (adenoviral vector bearing p53 gene) has been approved in China, in 2003. Still, while the majority of the data support a role for mutated p53 in reducing chemosensitvity, the other indicate either no correlation or even increased sensitivity to chemotherapeutic agents resulting in much experimental work tending to elucidate mechanisms for these contradictory results. Moreover, the cell-cycle regulator p21WAF1/CIP1 is one of the most important p53-regulated genes. Its role in the cell-response to therapy has become more and more complex and controversial since its discovery. Its induction is essential for the onset of cell cycle arrest in damage response and cell senescence and therefore implicated in response to many cancer treatments. However, its role in different forms of drug-induced cell death is not fully understood ; it could be either pro-, or anti- apoptotic and it highly depends on cell type and cellular context. Using adenoviruses for the introduction of p53 and p21WAF1/CIP1 genes to tumor cells, we are studying their roles and potentials of their exploitation in tumor therapy and some of our recent findings will be presented.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Projekti:
098-0982464-2514 - Uloga različitih mehanizama odgovora stanica na terapiju oštećenjem DNA (Kralj, Marijeta, MZOS ) ( CroRIS)
Ustanove:
Institut "Ruđer Bošković", Zagreb
Profili:
Marijeta Kralj
(autor)